Literature DB >> 28801197

Kinase inhibitors in clinical practice: An expanding world.

Ruchi Pandey1, Reuben Kapur2.   

Abstract

Entities:  

Keywords:  IPI-549; Kinase inhibitors; immune disorders; phosphoinositide 3-kinase

Mesh：

Substances：

Year:  2017        PMID： 28801197      PMCID： PMC5848208          DOI： 10.1016/j.jaci.2017.07.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models.

Authors:  Can Hekim; Mette Ilander; Jun Yan; Erin Michaud; Richard Smykla; Markus Vähä-Koskela; Paula Savola; Siri Tähtinen; Leena Saikko; Akseli Hemminki; Panu E Kovanen; Kimmo Porkka; Francis Y F Lee; Satu Mustjoki
Journal:  Cancer Immunol Res       Date:  2017-01-10       Impact factor: 11.151

2.  Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Authors:  Hannah Bower; Magnus Björkholm; Paul W Dickman; Martin Höglund; Paul C Lambert; Therese M-L Andersson
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.

Authors:  Kimberly M Sogi; Katie A Lien; Jeffrey R Johnson; Nevan J Krogan; Sarah A Stanley
Journal:  ACS Infect Dis       Date:  2017-06-05       Impact factor: 5.084

4.  Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.

Authors:  Kyle C Arend; Erik M Lenarcic; Heather A Vincent; Naim Rashid; Eric Lazear; Ian M McDonald; Thomas S K Gilbert; Michael P East; Laura E Herring; Gary L Johnson; Lee M Graves; Nathaniel J Moorman
Journal:  Mol Cell Proteomics       Date:  2017-02-25       Impact factor: 5.911

5.  Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.

Authors:  Olivier De Henau; Matthew Rausch; David Winkler; Luis Felipe Campesato; Cailian Liu; Daniel Hirschhorn Cymerman; Sadna Budhu; Arnab Ghosh; Melissa Pink; Jeremy Tchaicha; Mark Douglas; Thomas Tibbitts; Sujata Sharma; Jennifer Proctor; Nicole Kosmider; Kerry White; Howard Stern; John Soglia; Julian Adams; Vito J Palombella; Karen McGovern; Jeffery L Kutok; Jedd D Wolchok; Taha Merghoub
Journal:  Nature       Date:  2016-11-09       Impact factor: 49.962

6.  Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.

Authors:  Willy Hugo; Jesse M Zaretsky; Lu Sun; Chunying Song; Blanca Homet Moreno; Siwen Hu-Lieskovan; Beata Berent-Maoz; Jia Pang; Bartosz Chmielowski; Grace Cherry; Elizabeth Seja; Shirley Lomeli; Xiangju Kong; Mark C Kelley; Jeffrey A Sosman; Douglas B Johnson; Antoni Ribas; Roger S Lo
Journal:  Cell       Date:  2016-03-17       Impact factor: 41.582

7.  PI3Kγ is a molecular switch that controls immune suppression.

Authors:  Megan M Kaneda; Karen S Messer; Natacha Ralainirina; Hongying Li; Christopher J Leem; Sara Gorjestani; Gyunghwi Woo; Abraham V Nguyen; Camila C Figueiredo; Philippe Foubert; Michael C Schmid; Melissa Pink; David G Winkler; Matthew Rausch; Vito J Palombella; Jeffery Kutok; Karen McGovern; Kelly A Frazer; Xuefeng Wu; Michael Karin; Roman Sasik; Ezra E W Cohen; Judith A Varner
Journal:  Nature       Date:  2016-09-19       Impact factor: 49.962

Review 8.  Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib.

Authors:  Rossana Maffei; Stefania Fiorcari; Silvia Martinelli; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  J Hematol Oncol       Date:  2015-05-29       Impact factor: 17.388

9.  Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.

Authors:  Mara Compagno; Qi Wang; Chiara Pighi; Taek-Chin Cheong; Fei-Long Meng; Teresa Poggio; Leng-Siew Yeap; Elif Karaca; Rafael B Blasco; Fernanda Langellotto; Chiara Ambrogio; Claudia Voena; Adrian Wiestner; Siddha N Kasar; Jennifer R Brown; Jing Sun; Catherine J Wu; Monica Gostissa; Frederick W Alt; Roberto Chiarle
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962
  9 in total
  2 in total

1.  The non-linearity of RAF-MEK signaling in dendritic cells.

Authors:  Kristina Riegel; Krishnaraj Rajalingam
Journal:  Cell Cycle       Date:  2020-08-04       Impact factor: 4.534

Review 2.  Production of β-Lactamase Inhibitors by Streptomyces Species.

Authors:  Daniela de Araújo Viana Marques; Suellen Emilliany Feitosa Machado; Valéria Carvalho Santos Ebinuma; Carolina de Albuquerque Lima Duarte; Attilio Converti; Ana Lúcia Figueiredo Porto
Journal:  Antibiotics (Basel)       Date:  2018-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.